🔎 Trials Near Me

Dachaigh › Glioblastoma › North Carolina › Durham

Sgrùdaidhean clionaigeach Glioblastoma ann an Durham, NC

Tha 20 sgrùdaidhean airson Glioblastoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Durham (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

A’ fastadhÌre 3
  • University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05902169

Targeted Pediatric High-Grade Glioma Therapy

A’ fastadhSgrùdadh amharc
  • Duke University Health System, Durham
12 Months – 39 Years · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

A’ fastadhÌre 2
  • Duke University Health System, Durham
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

A’ fastadhÌre 3
  • Duke Cancer Institute, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT05303519

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT04903795

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

A’ fastadhÌre 2
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT06319027

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

A’ fastadhÌre 2
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT05708352

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

A’ fastadhÌre 2
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 31 Iuch 2026 · NCT06069726

Lerapolturev (PVSRIPO) in GBM

A’ fastadhÌre 2
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT06177964

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

A’ fastadhÌre 2
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06805305

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

A’ fastadhÌre 1 tràthFàilte do shaor-thoilich fhallain
  • Duke University Health System, Durham
Aoisean 1 gu 21 · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT06333899

Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT04547777

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

A’ fastadhÌre 2
  • Duke University Health System, Durham
12 Months – 39 Years · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT05843253

Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc

A’ fastadhÌre 1
  • Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Gibl 2026 · NCT05366179

Key Longitudinal Associations With Risk and Glioblastoma Outcomes

A’ fastadhSgrùdadh amharc
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Faoi 2026 · NCT06625684

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, Chapel Hill · 10 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

D2C7-IT + 2141-V11 Combination Post-resection in rGBM

A’ fastadhÌre 1
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Dàmh 2025 · NCT06455605

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

A’ fastadhÌre 1/2
  • Duke University Medical Center, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Dàmh 2025 · NCT05734560

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

A’ fastadhÌre 2
  • University of North Carolina, Chapel Hill · 10 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Ògmh 2025 · NCT03175224

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

A’ fastadhÌre 1
  • Duke University, Durham
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Ògmh 2025 · NCT05879367

Sgrùdaidhean Glioblastoma ann am bailtean eile

Sgrùdaidhean eile ann an Durham

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.